MedTrace Logo

Bilateral Cervical Plexus Block for Postoperative Pain After Thyroidectomy

NCT07496970 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-03-27

No results posted yet for this study

Summary

Patients undergoing thyroidectomy frequently experience moderate postoperative pain that may require opioid analgesics. Opioid use is associated with adverse effects such as nausea, vomiting, respiratory depression, and delayed recovery. Ultrasound-guided regional anesthesia techniques may provide effective postoperative analgesia while reducing opioid consumption.

The aim of this prospective randomized study was to evaluate the analgesic efficacy of ultrasound-guided bilateral superficial cervical plexus block (BSCPB) in patients undergoing thyroidectomy under general anesthesia. Patients were divided into two groups: a block group receiving BSCPB with 0.5% bupivacaine and a control group receiving general anesthesia alone. Postoperative pain scores, opioid consumption, intraoperative analgesic requirements, and postoperative complications were compared between the groups.

Conditions

  • Postoperative Pain

Interventions

PROCEDURE

Ultrasound-Guided Bilateral Superficial Cervical Plexus Block

Intervention Description: Patients received an ultrasound-guided bilateral superficial cervical plexus block prior to surgery. A total of 20 ml of 0.5% bupivacaine (10 ml per side) was injected along the posterior border of the sternocleidomastoid muscle using the three-injection technique. The block was performed under ultrasound guidance before induction of general anesthesia to provide perioperative analgesia.

PROCEDURE

Standard general anesthesia

only general anesthesia

Sponsors & Collaborators

  • University of Gaziantep

    lead OTHER

Principal Investigators

  • Elzem Sen, Assoc Prof · University of Gaziantep

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-15
Primary Completion
2023-06-30
Completion
2023-07-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07496970 on ClinicalTrials.gov